A tumor-imaging method targeting cancer-associated fibroblasts

The tumor stroma, which accounts for a large part of the tumor mass, represents an attractive target for the delivery of diagnostic and therapeutic compounds. Here, the focus is notably on a subpopulation of stromal cells, known as cancer-associated fibroblasts, which are present in more than 90% of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Loktev, Anastasia (VerfasserIn) , Lindner, Thomas (VerfasserIn) , Mier, Walter (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Altmann, Annette (VerfasserIn) , Jäger, Dirk (VerfasserIn) , Giesel, Frederik L. (VerfasserIn) , Kratochwil, Clemens (VerfasserIn) , Barthe, Philippe (VerfasserIn) , Roumestand, Christian (VerfasserIn) , Haberkorn, Uwe (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: Apr. 6, 2018
In: Journal of nuclear medicine
Year: 2018, Jahrgang: 59, Heft: 9, Pages: 1423-1429
ISSN:2159-662X
DOI:10.2967/jnumed.118.210435
Online-Zugang:Verlag, Volltext: https://doi.org/10.2967/jnumed.118.210435
Verlag: http://jnm.snmjournals.org/content/59/9/1423
Volltext
Verfasserangaben:Anastasia Loktev, Thomas Lindner, Walter Mier, Jürgen Debus, Annette Altmann, Dirk Jäger, Frederik Giesel, Clemens Kratochwil, Philippe Barthe, Christian Roumestand, and Uwe Haberkorn

MARC

LEADER 00000caa a2200000 c 4500
001 1691220124
003 DE-627
005 20230428055024.0
007 cr uuu---uuuuu
008 200228s2018 xx |||||o 00| ||eng c
024 7 |a 10.2967/jnumed.118.210435  |2 doi 
035 |a (DE-627)1691220124 
035 |a (DE-599)KXP1691220124 
035 |a (OCoLC)1341308492 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Loktev, Anastasia  |e VerfasserIn  |0 (DE-588)1160315728  |0 (DE-627)1023462869  |0 (DE-576)505840170  |4 aut 
245 1 2 |a A tumor-imaging method targeting cancer-associated fibroblasts  |c Anastasia Loktev, Thomas Lindner, Walter Mier, Jürgen Debus, Annette Altmann, Dirk Jäger, Frederik Giesel, Clemens Kratochwil, Philippe Barthe, Christian Roumestand, and Uwe Haberkorn 
264 1 |c Apr. 6, 2018 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.02.2020 
520 |a The tumor stroma, which accounts for a large part of the tumor mass, represents an attractive target for the delivery of diagnostic and therapeutic compounds. Here, the focus is notably on a subpopulation of stromal cells, known as cancer-associated fibroblasts, which are present in more than 90% of epithelial carcinomas, including pancreatic, colon, and breast cancer. Cancer-associated fibroblasts feature high expression of fibroblast activation protein (FAP), which is not detectable in adult normal tissue but is associated with a poor prognosis in cancer patients. Methods: We developed an iodinated and a DOTA-coupled radiotracer based on a FAP-specific enzyme inhibitor (FAPI) and evaluated them in vitro using uptake, competition, and efflux studies as well as confocal microscopy of a fluorescence-labeled variant. Furthermore, we performed imaging and biodistribution studies on tumor-bearing animals. Finally, proof of concept was realized by imaging patients with 68Ga-labeled FAPI. Results: Both FAPIs showed high specificity, affinity, and rapid internalization into FAP-expressing cells in vitro and in vivo. Biodistribution studies on tumor-bearing mice and on the first cancer patients demonstrated high intratumoral uptake of the tracer and fast body clearance, resulting in high-contrast images and negligible exposure of healthy tissue to radiation. A comparison with the commonly used radiotracer 18F-FDG in a patient with locally advanced lung adenocarcinoma revealed that the new FAP ligand was clearly superior. Conclusion: Radiolabeled FAPIs allow fast imaging with very high contrast in tumors having a high stromal content and may therefore serve as pantumor agents. Coupling of these molecules to DOTA or other chelators allows labeling not only with 68Ga but also with therapeutic isotopes such as 177Lu or 90Y. 
650 4 |a activated fibroblasts 
650 4 |a FAP 
650 4 |a PET 
650 4 |a radiopharmaceuticals 
650 4 |a small molecule 
650 4 |a tumor 
700 1 |a Lindner, Thomas  |e VerfasserIn  |0 (DE-588)107520318X  |0 (DE-627)833005804  |0 (DE-576)443314772  |4 aut 
700 1 |a Mier, Walter  |d 1966-  |e VerfasserIn  |0 (DE-588)12029026X  |0 (DE-627)69653567X  |0 (DE-576)292141599  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Altmann, Annette  |e VerfasserIn  |0 (DE-588)1032267984  |0 (DE-627)738189111  |0 (DE-576)379930099  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Giesel, Frederik L.  |d 1970-  |e VerfasserIn  |0 (DE-588)129031240  |0 (DE-627)387883878  |0 (DE-576)297457071  |4 aut 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
700 1 |a Barthe, Philippe  |e VerfasserIn  |4 aut 
700 1 |a Roumestand, Christian  |e VerfasserIn  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
773 0 8 |i Enthalten in  |t Journal of nuclear medicine  |d New York, NY : Soc., 1964  |g 59(2018), 9, Seite 1423-1429  |h Online-Ressource  |w (DE-627)325793603  |w (DE-600)2040222-3  |w (DE-576)09475277X  |x 2159-662X  |7 nnas  |a A tumor-imaging method targeting cancer-associated fibroblasts 
773 1 8 |g volume:59  |g year:2018  |g number:9  |g pages:1423-1429  |g extent:7  |a A tumor-imaging method targeting cancer-associated fibroblasts 
856 4 0 |u https://doi.org/10.2967/jnumed.118.210435  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://jnm.snmjournals.org/content/59/9/1423  |x Verlag 
951 |a AR 
992 |a 20200228 
993 |a Article 
994 |a 2018 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 11  |y j 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 129031240  |a Giesel, Frederik L.  |m 129031240:Giesel, Frederik L.  |d 910000  |d 911400  |e 910000PG129031240  |e 911400PG129031240  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 6 
998 |g 1032267984  |a Altmann, Annette  |m 1032267984:Altmann, Annette  |d 910000  |d 911400  |e 910000PA1032267984  |e 911400PA1032267984  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 12029026X  |a Mier, Walter  |m 12029026X:Mier, Walter  |d 910000  |d 911400  |e 910000PM12029026X  |e 911400PM12029026X  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 107520318X  |a Lindner, Thomas  |m 107520318X:Lindner, Thomas  |d 910000  |d 911400  |e 910000PL107520318X  |e 911400PL107520318X  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1160315728  |a Loktev, Anastasia  |m 1160315728:Loktev, Anastasia  |d 910000  |d 911400  |e 910000PL1160315728  |e 911400PL1160315728  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1691220124  |e 359915886X 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1691220124","relHost":[{"corporate":[{"display":"Society of Nuclear Medicine","role":"isb"}],"language":["eng"],"titleAlt":[{"title":"JNM"}],"part":{"extent":"7","volume":"59","issue":"9","text":"59(2018), 9, Seite 1423-1429","pages":"1423-1429","year":"2018"},"title":[{"title":"Journal of nuclear medicine","subtitle":"JNM","title_sort":"Journal of nuclear medicine"}],"origin":[{"publisherPlace":"New York, NY","dateIssuedKey":"1964","publisher":"Soc.","dateIssuedDisp":"1964-"}],"pubHistory":["Nachgewiesen 5.1964 -"],"note":["Gesehen am 13.12.2021"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"A tumor-imaging method targeting cancer-associated fibroblastsJournal of nuclear medicine","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Society of Nuclear Medicine"]},"recId":"325793603","id":{"zdb":["2040222-3"],"issn":["2159-662X","1535-5667"],"eki":["325793603"]}}],"name":{"displayForm":["Anastasia Loktev, Thomas Lindner, Walter Mier, Jürgen Debus, Annette Altmann, Dirk Jäger, Frederik Giesel, Clemens Kratochwil, Philippe Barthe, Christian Roumestand, and Uwe Haberkorn"]},"physDesc":[{"extent":"7 S."}],"id":{"doi":["10.2967/jnumed.118.210435"],"eki":["1691220124"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"Apr. 6, 2018"}],"note":["Gesehen am 28.02.2020"],"title":[{"title_sort":"tumor-imaging method targeting cancer-associated fibroblasts","title":"A tumor-imaging method targeting cancer-associated fibroblasts"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"display":"Loktev, Anastasia","family":"Loktev","given":"Anastasia","role":"aut"},{"display":"Lindner, Thomas","family":"Lindner","role":"aut","given":"Thomas"},{"display":"Mier, Walter","family":"Mier","role":"aut","given":"Walter"},{"role":"aut","given":"Jürgen","family":"Debus","display":"Debus, Jürgen"},{"given":"Annette","role":"aut","display":"Altmann, Annette","family":"Altmann"},{"given":"Dirk","role":"aut","display":"Jäger, Dirk","family":"Jäger"},{"display":"Giesel, Frederik L.","family":"Giesel","given":"Frederik L.","role":"aut"},{"family":"Kratochwil","display":"Kratochwil, Clemens","role":"aut","given":"Clemens"},{"role":"aut","given":"Philippe","family":"Barthe","display":"Barthe, Philippe"},{"display":"Roumestand, Christian","family":"Roumestand","given":"Christian","role":"aut"},{"family":"Haberkorn","display":"Haberkorn, Uwe","given":"Uwe","role":"aut"}]} 
SRT |a LOKTEVANASTUMORIMAGI6201